TrialBMC cancer2022

Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study.

F F Pepe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.